JARDY MET XR 12.5/1000MG TABLET

JARDY MET XR 12.5/1000MG TABLET is a medication that combines two active ingredients, Empagliflozin & Metformin, in extended-release form. Empagliflozin belongs to a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors, while Metformin is a biguanide. This combination is used to treat type 2 diabetes mellitus in adults by helping to control blood sugar levels.

Uses:

1. Type 2 Diabetes Mellitus: JARDY MET XR 12.5/1000MG TABLET is prescribed for the management of type 2 diabetes mellitus in adults. It helps to lower blood sugar levels by increasing the excretion of glucose through urine and reducing the production of glucose in the liver. This medication is typically used alongside diet and exercise to improve glycemic control.

Side Effects:

JARDY MET XR 12.5/1000MG TABLET may cause some side effects in certain individuals. It is important to note that not all users will experience these side effects, and some may experience none at all. Common side effects may include:

1. Hypoglycemia: Low blood sugar levels may occur, leading to symptoms such as shakiness, dizziness, sweating, confusion, and headache.
2. Urinary Tract Infections: Empagliflozin, one of the active ingredients, can increase the risk of developing urinary tract infections.
3. Genital Infections: Some individuals may experience genital yeast infections or urinary tract infections.
4. Increased Urination: Empagliflozin can increase the frequency of urination.
5. Gastrointestinal Issues: Digestive problems such as diarrhea, nausea, and stomach discomfort may occur.
6. Dehydration: In rare cases, excessive loss of body fluids may lead to dehydration.

It is essential to consult a healthcare professional for a complete list of possible side effects, as well as any severe or persistent symptoms that may require medical attention.

When Not to Use:

JARDY MET XR 12.5/1000MG TABLET should not be used in certain situations. These include:

1. Type 1 Diabetes: This medication is specifically for type 2 diabetes and should not be used to treat type 1 diabetes.
2. Diabetic Ketoacidosis: JARDY MET XR 12.5/1000MG TABLET should not be used in individuals with diabetic ketoacidosis, a serious complication of diabetes.
3. Severe Kidney Impairment: If you have severe kidney problems or are undergoing dialysis, this medication may not be suitable for you.
4. Hypersensitivity: Individuals who are allergic or hypersensitive to Empagliflozin, Metformin, or any other components of the medication should not use JARDY MET XR 12.5/1000MG TABLET.

It is crucial to inform your healthcare provider about any existing medical conditions, allergies, or medications you are currently taking before starting this medication.

Note: The information provided here is a general overview and should not be used as a substitute for professional medical advice. Always consult your healthcare provider or pharmacist for personalized guidance based on your specific circumstances.